Fetal Growth Restriction (FGR)
10
6
6
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
10.0%
1 terminated out of 10 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)
Placental Imaging Techniques
AI-Based Ultrasound Prediction of Pregnancy Outcomes in Placental-Related Fetal Growth Restriction (MVM-FGR): A Prospective Cohort Study
Placental Biology in Health and Disease
Amniotic Fluid & the Preterm Gut
Association of Assisted Reproductive Technologies Parameters With the Perinatal Outcome
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
Observational Study on Fetal Growth Restriction Complicated by Early Flowmetric Alterations
Diagnostic Value of sFlt-1/PlGF Ratio for the Etiology of Intra Uterine Growth Restriction - ANGIOPAG
Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction